StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.53−0.03 (-1.92%)

Close on Nov 17, 2026Market cap $2.00MP/E –Yield –

Can-Fite BioPharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Can-Fite BioPharma's price to book ratio was 0.7× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.6× to 5.6×, with a median of 1.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×+0.1
2025Dec 31, 20250.6×−3.0
2024Dec 31, 20243.7×+2.3
2023Dec 29, 20231.3×−0.4
2022Dec 30, 20221.7×−3.9
2021Dec 31, 20215.6×+2.9
2020Dec 31, 20202.7×+1.4
2019Jul 31, 20191.3×−5.1
2018Jul 31, 20186.4×+2.9
2017Dec 29, 20173.5×–

More Can-Fite BioPharma figures

See a number that looks wrong?